Regulatory fluctuations, corporate challenges, cross-category intersections, adult-use dominance, the ongoing rise of HDIC products and tailored product offerings are resulting in both challenges and opportunities for the cannabis industry.
Delivery
This report comes in PPT.
Cannabis regulatory developments are often hard to predict. This is likely to continue to be the case in the forecast period, especially as geopolitical and socioeconomic conflicts and challenges intensify. In this context, and considering the complexities that characterise the cannabis industry, governments are unlikely to see cannabis legalisation as a top priority.
Although the opening of the cannabis industry has been occurring across the medical, CBD & other non-intoxicating cannabinoids, and adult-use categories, the latter is usually the most influential category in terms of revenue generation and impact on general cannabis-related legislative developments.
Hemp-derived intoxicating products are still proliferating, and the consequences are manifold. While it has been enhancing the competition with the legal adult-use category and increasing the chances of cannabis scrutiny from governmental bodies, health authorities and consumers, it has also been opening revenue opportunities in markets in which HDIC products are regulated.
Cannabis product innovation has been touching on a range of features and functionalities, making them more appealing to a wider breadth of consumers and consequently increasing the “democratisation” and “normalisation” of cannabis.
The last couple of years have been challenging for some cannabis companies, most notably in mature markets such as the US and Canada. Unclear legislative frameworks, high tax burdens, oversupply issues, price decreases, low profitability and an uncertain macroeconomic scenario are among the difficulties that cannabis players have had to confront.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!